As CMS delays its decision on OR’s drug exclusions,

CMS Targets TennCare’s Closed Drug Formulary In Revamp Request

By John Wilkerson / July 1, 2022 at 5:30 PM
CMS officials delayed a decision on Oregon’s request to exclude accelerated approval drugs from coverage on the same day that they asked Tennessee’s Medicaid officials to withdraw their closed drug formulary from TennCare’s Medicaid program, and CMS wants TennCare to revamp its block-grant-like program to ensure that Medicaid beneficiaries are protected. CMS doesn’t call TennCare’s capped Medicaid funding demonstration a block grant, but the amount of money the state gets is capped. In exchange for capping federal funding, Tennessee may...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.